Chemotherapy-Induced Peripheral Neuropathy: Current Status and Progress

by Brewer, Jamie R, Morrison, Gladys, Dolan, M. Eileen, Fleming, Gini F
Published in Gynecol Oncol (2015)

Evaluation of Inter-Batch Differences in Stem-Cell Derived Neurons

by Morrison, Gladys, Liu, Cong, Wing, Claudia, Delaney, Shannon M, Zhang, Wei, Dolan, M. Eileen
Published in Stem Cell Res (2015)

Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile

by Wang, Fan, Chang, Jeremy T-H., Zhang, Zhenyu, Morrison, Gladys, Nath, Aritro, Bhutra, Steven, Huang, Rong Stephanie
Published in Oncotarget (2017)

Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling

by Gruener, Robert F., Ling, Alexander, Chang, Ya-Fang, Morrison, Gladys, Geeleher, Paul, Greene, Geoffrey L., Huang, R. Stephanie
Published in Cancers (Basel) (2021)

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies

by Geeleher, Paul, Zhang, Zhenyu, Wang, Fan, Gruener, Robert F., Nath, Aritro, Morrison, Gladys, Bhutra, Steven, Grossman, Robert L., Huang, R. Stephanie
Published in Genome Res (2017)

THERAPEUTIC POTENTIAL OF THE DUAL EGFR/HER2 INHIBITOR AZD8931 IN CIRCUMVENTING ENDOCRINE RESISTANCE

by Morrison, Gladys, Fu, Xiaoyong, Shea, Marty, Nanda, Sarmistha, Giuliano, Mario, Wang, Tao, Klinowska, Teresa, Osborne, C. Kent, Rimawi, Mothaffar F., Schiff, Rachel
Published 2014

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer

by Bu, Wen, Chen, Jiang, Morrison, Gladys D., Huang, Shixia, Creighton, Chad J., Huang, Jian, Chamness, Gary C., Hilsenbeck, Susan G., Roop, Dennis R., Leavitt, Andrew D., Li, Yi
Published 2011

The NMDAR modulator NYX-2925 alleviates neuropathic pain via a Src-dependent mechanism in the mPFC

by Morrison, Gladys, Asiedu, Marina N., Priebe, Jessica M., Dunning, Jacqueline, Ghoreishi-Haack, Nayereh, Kroes, Roger A., Bowers, M. Scott, Barth, Amanda L., Cearley, Cassia N., Moskal, Joseph R.
Published in Neurobiol Pain (2019)

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients

by Morrison, Gladys, Lenkala, Divya, LaCroix, Bonnie, Ziliak, Dana, Abramson, Vandana, Morrow, Phuong Khanh, Forero, Andres, Van Poznak, Catherine, Rugo, Hope S, Nanda, Rita, O'Donnell, Peter H., Huang, R. Stephanie
Published in Oncotarget (2016)

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation

by Wang, Yen-Chao, Morrison, Gladys, Gillihan, Ryan, Guo, Jun, Ward, Robin M, Fu, Xiaoyong, Botero, Maria F, Healy, Nuala A, Hilsenbeck, Susan G, Phillips, Gail Lewis, Chamness, Gary C, Rimawi, Mothaffar F, Osborne, C Kent, Schiff, Rachel
Published 2011

Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-a...

by Fu, Xiaoyong, Creighton, Chad J, Biswal, Nrusingh C, Kumar, Vijetha, Shea, Martin, Herrera, Sabrina, Contreras, Alejandro, Gutierrez, Carolina, Wang, Tao, Nanda, Sarmistha, Giuliano, Mario, Morrison, Gladys, Nardone, Agostina, Karlin, Kristen L, Westbrook, Thomas F, Heiser, Laura M, Anur, Pavana, Spellman, Paul, Guichard, Sylvie M, Smith, Paul D, Davies, Barry R, Klinowska, Teresa, Lee, Adrian V, Mills, Gordon B, Rimawi, Mothaffar F, Hilsenbeck, Susan G, Gray, Joe W, Joshi, Amit, Osborne, C Kent, Schiff, Rachel
Published in Breast Cancer Res (2014)